GTI acquires Precision Specialized, a division of Precision Truck Lines

Novacap

Montreal, February 11, 2018 – GTI Transport Solution Inc (“GTI”), a leading provider of open-deck, specialized and over-dimensional freight services, a Novacap-backed company, announces it is acquiring Precision Specialized Division Inc. (PSD), a division of Precision Truck Lines Inc. Located in Woodbridge, Ontario, PSD is a leader of open-deck and heavy haul transportation in the province. All employee positions at the division, including management roles, will be maintained. GTI plans to invest in the company’s growing operations by expanding into new markets. This will begin with all operations moving to Brantford, Ontario and a unified name change to Precision Specialized Inc (“PSI”).

GTI acquires Precision Specialized, a division of Precision Truck Lines

“The team at Precision Specialized has demonstrated market leading know-how in quality of service and engineering of complex project driven loads,” says Richard Lafrenière, CEO of GTI. “We firmly believe that blending their expertise with the broad footprint of GTI will enable us to drive growth and become the preferred open-deck/heavy haul transportation company in North America.”

“This acquisition is a continuation of GTI’s strategic plan to expand its current capabilities and geographic reach,” says Frédérick Perrault, Senior Partner of Novacap. “Combined with the launch of GTI USA in 2018 and other acquisitions in the pipeline, we are very enthusiastic about the group’s future.”

Ed Bernard, former VP of Precision Specialized Division Inc. will continue in his current role and more, now serving as President of Precision Specialized Inc. Mr. Bernard adds, “Precision Specialized is proud to be joining forces with GTI to propel our company to the next phase of its growth. A team of seasoned managers will bring valuable expertise and an injection of fresh capital will enable us to better serve our customers across North America. Moving operations 60 miles to Brantford gives us much needed space for our growing equipment assets.”

“This transaction is a win-win for us,” says Ravi Annand, Vice-President & CFO of Precision Truck Lines, “It will allow a great division we have built up over the last decade to continue its growth plan and allow Precision Truck Lines to focus on its core activities of TL and LTL Transborder transportation.”

 

About GTI

GTI Transport Solutions (“GTI”) specializes in open-deck, heavy haul and over dimensional transportation services while also offering specialty storage, logistics and freight forwarding services. GTI has fully equipped transportation terminals in Quebec and Ontario and 300,000 sq.ft. of specialized warehousing. For further information, visit www.thegtigroup.com

 

About Precision Truck Lines

Precision is a family-based business that combines state-of-the art trucking technology with old-fashioned business values to ensure our customers’ project needs are met and their expectations are exceeded. With a commitment to hard work, teamwork, honesty, and exceptional customer service, Precision has grown steadily into one of the best managed transportation companies in North America. For further information, visit www.precisiontrucklines.com

 

About Novacap

Founded in 1981, Novacap is a leading Canadian private equity firm with $2.3 billion of assets under management. Novacap’s unique investment approach, based on deep operational expertise and an active partnership with entrepreneurs, has helped accelerate growth and create long-term value for its numerous investee companies. With an experienced management team and substantial financial resources, Novacap is well positioned to continue building world-class companies. For more information, please visit www.novacap.ca.

Source: Novacap / GTI 

Media contacts:

For Novacap and GTI:

Valérie Gonzalo

AGO Communications

514.626.6976

valerie@agocom.ca

Categories: News

Tags:

NPM expands minority interest in SUITSUPPLY

NPM Capital

Private equity firm NPM Capital has strengthened its participation in Suitsupply by providing further growth capital. At the end of 2017, NPM Capital invested a first tranche, which allowed Suitsupply to open 25 stores and grow the organization.

Commercially, the company is developing well. Global sales have grown, particularly in the US and Asia. The Suistudio women’s line has been expanded with stores in Milan, Shanghai, Frankfurt and New York. Furthermore, Suitsupply is capitalizing on the casualization trend by offering more clothes that can be worn with a suit or a jacket. Digital development remains a spearhead, with an increasing symbiosis between the physical stores and the webshop. An example is the digital fitting room, where customers decide online what items should be ready for them in a fitting room.

The second tranche of growth capital that NPM Capital has provided will be used for the further development of the omnichannel retail concept, the conversion and restyling of existing stores and the opening of new stores, with a focus on China.

Read more NPM invests in Suitsupply’s growth

 

Categories: News

Tags:

Veritas Capital Completes Acquisition of athenahealth

Veritas Capital

Evergreen Coast Capital to be Minority Investor in Combination of athenahealth and Veritas-Backed Virence

Bob Segert to Serve as Chairman and CEO

WATERTOWN, MA. and NEW YORK, NY. –  athenahealth, Inc., a leading provider of network-enabled services for hospital and ambulatory customers nationwide, announced today that it has completed its previously announced sale to an affiliate of Veritas Capital (“Veritas”) and Evergreen Coast Capital (“Evergreen”) for approximately $5.7 billion in cash.

Virence Health (“Virence”), the former GE Healthcare Value-based Care assets that Veritas acquired in 2018, will combine with athenahealth under the athenahealth name and brand. The combined company will be led by Virence Chairman and Chief Executive Officer Bob Segert and an executive leadership team comprised of executives from both companies, and will be headquartered on the athenahealth campus in Watertown, Massachusetts. As part of the transaction, Virence’s Workforce Management business becomes a separate Veritas portfolio company under the API Healthcare brand.

“The combination of athenahealth and Virence brings together two innovative companies with complementary expertise and a shared focus and passion for improving healthcare outcomes.  With a network of over 160,000 providers, the combined company is positioned for future growth and new market opportunities and has the necessary scale to make a transformational impact in the healthcare industry,” said Ramzi Musallam, CEO and Managing Partner of Veritas Capital. “We look forward to leveraging our experience in healthcare IT to support Bob Segert and the leadership team in their mission to help clients succeed.”

Bob Segert, Chairman and CEO of the combined company, said: “athenahealth is one of the most unique and valuable assets in healthcare – with industry-leading solutions and a vision and model for delivering financial and clinical results for providers. By combining our companies’ cultures, solutions and teams, we have an opportunity to accelerate that vision, achieving a scale that will allow us to unlock new value for all of our customers. Today marks the first step in our new journey as a united team, and we are more committed than ever to investing in innovation, delivering a superior customer experience, and continuing our collective mission to transform healthcare.”

Evergreen Managing Director Isaac Kim said, “We are pleased to have completed this transaction along with our partners at Veritas.  The combination of athenahealth and Virence creates an industry leader poised to drive the future of healthcare IT.”

The transaction was announced on November 12, 2018 and received approval from athenahealth shareholders on February 7, 2019. As a result of the completion of the transaction, shares of athenahealth common stock will be removed from listing on Nasdaq, with trading in athenahealth shares to be suspended following the closing of business today.

About athenahealth, Inc.

athenahealth partners with hospital and ambulatory customers to drive clinical and financial results. We offer medical record, revenue cycle, patient engagement, care coordination, and population health services. We combine insights from our network of more than 120,000 providers and approximately 117 million patients with deep industry knowledge and perform administrative work at scale. For more information, please visit www.athenahealth.com.

About Virence Health

Virence Health Technologies is a leading software provider that leverages technology and analytics to help healthcare providers across the continuum of care effectively manage their financial, clinical, and human capital workflows. Offering a comprehensive suite of innovative technology-enabled solutions, Virence aims to improve quality, increase efficiency, and reduce waste in the healthcare industry. Learn more at www.virencehealth.com.

About Veritas Capital

Veritas Capital is a leading private equity firm that invests in companies that provide critical products and services, primarily technology and technology-enabled solutions, to government and commercial customers worldwide, including those operating in the aerospace & defense, healthcare, software, national security, communications, energy, government services and education industries. Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means. For more information on Veritas Capital and its current and past investments, visit www.veritascapital.com.

About Elliott and Evergreen Coast Capital

Elliott Management Corporation manages two multi-strategy investment funds which combined have approximately $34 billion of assets under management. Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds of its kind under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. This investment is being led by Evergreen Coast Capital, Elliott’s Menlo Park affiliate, which focuses on technology investing.

Media Contacts:

athenahealth
John Fox / Finley Hines
media@athenahealth.com
(617) 402-8001

Virence/Veritas Capital
Andrew Cole / David Millar / Julie Rudnick
Sard Verbinnen & Co
(212) 687-8080
virence-svc@sardverb.com

Elliott Management Corporation/Evergreen Coast Capital 
Stephen Spruiell
(212) 478-2017
sspruiell@elliottmgmt.com

Categories: News

Francisco Partners Acquires Qualcomm Life

Franciso Partners

Acquisition positions standalone company to focus on growth opportunities

SAN FRANCISCO AND SAN DIEGO – Francisco Partners (“FP”), a leading technology-focused private equity firm, today announced it has acquired Qualcomm Life, Inc. a wholly owned subsidiary of Qualcomm Incorporated that offers end-to-end medical device connectivity across the continuum of care.

Qualcomm Life will be separated from Qualcomm, be renamed as Capsule Technologies, Inc. (“CapsuleTech”), and continue operating its two distinct business segments: Capsule (a leading provider of medical device connectivity solutions for hospitals) and 2net™ (a medical grade mobile connectivity platform).

“Francisco Partners’ deep experience in healthcare technology and proven track record in nurturing and growing technology businesses will enable CapsuleTech’s loyal base of employees to continue delivering innovation,” said Duane Nelles, Senior Vice President of Corporate Development at Qualcomm Incorporated. “We look forward to our partnership with the FP team as they grow CapsuleTech as an independent entity.”

“FP’s acquisition will help Qualcomm Life (now CapsuleTech) continue to deliver market leading products and services to its world class customer base,” said Rick Valencia, former President of Qualcomm Life, who will support CapsuleTech as an advisor in its transition to a standalone company.

Capsule is a leading medical device connectivity platform that connects medical devices to clinical information systems in over 2,000 hospitals in approximately 40 countries. Through Capsule’s connected devices, networking solutions, and intelligent software applications, hospitals can capture and visualize clinical data to monitor patient health and improve patient care.

“Capsule is a key enabler of the digital hospital and is a trusted choice among hospital clinicians, IT administrators, and healthcare IT vendors,” said Chris Adams, Partner with Francisco Partners. “As hospitals continue to adopt data-driven approaches to managing patient care, Capsule stands to benefit by serving as a centralized connectivity hub for clinical information. We are excited to partner with Capsule and to help the team capitalize on new innovations in device technology and software applications.”

2net provides wireless mobile device connectivity via cloud-based solutions so biometric information is easily accessible by device users, health care providers, and payors. 2net’s customers include leading health insurance payors, pharmaceutical companies, and medical device manufacturers.

“Capsule and 2net will continue to drive increased focus on their respective customers, deliver mission critical solutions and provide exceptional service,” said Justin Chen, Vice President with Francisco Partners. “We look forward to supporting the talented employees and management team going forward.”

Centerview Partners served as financial advisor and DLA Piper LLP served as legal advisor to Qualcomm Incorporated. Kirkland & Ellis LLP served as legal advisor to Francisco Partners. Terms of the transaction were not disclosed.

About Capsule

Capsule is the leading global provider of medical device connectivity solutions for hospitals. Through its medical device technology and software, Capsule integrates with clinical information systems to capture more data, reduce manual efforts and cost, and improve patient care. Capsule’s medical grade solution is device and IT system agnostic, which enables it to meet the needs of any hospital or health system worldwide. Founded in 1997, Capsule has established strategic partnerships with leading medical device manufacturers and is installed in over 2,000 hospitals in 40 countries. For more information, please visit www.capsuletech.com.

About 2net

Founded in 2011, 2net is a medical grade mobile connectivity platform for third party application and device manufacturers focused on home and ambulatory use cases. 2net™ Platform and Hub unlock vital health and therapy data for integration with virtually any system, application or portal. The products interconnect wireless medical devices via cloud-based solutions so that biometric information is easily accessible by device users, health care providers and payors, and caregivers. 2net has over 40 customers and collaborators across health insurance payers, pharmaceutical companies, and medical device manufacturers. For more information, please visit www.2net.com.

About Francisco Partners

Francisco Partners is a leading global private equity firm that specializes in investments in technology and technology-enabled businesses. Since its launch over 19 years ago, Francisco Partners has raised over $14 billion in capital and invested in more than 200 technology companies, making it one of the most active and longstanding investors in the technology industry. The firm invests in opportunities where its deep knowledge and operational expertise can help companies realize their full potential. For more information on Francisco Partners, please visit www.franciscopartners.com.

Categories: News

Tags:

Active Capital Company and management invest in SchahlLED

ActiveCapital

Turnkey service provider of intelligent industrial LED solutions to strengthen its market
position with support from hands-on investor

Munich, 11 February 2019 – SchahlLED is a leading turnkey service provider of Intelligent LED solutions
for primarily industrial applications in the DACH region. As the pioneer in intelligent radio-controlled
lighting systems for industrial applications in DACH, SchahlLED has accumulated 7 years and several
hundred projects of expertise. The cutting edge intelligent LED solutions save up to 95% of energy costs
versus traditional lighting as well as significant energy savings versus regular LED and are used in
production facilities, warehouses, parking garages and cold storages. The typical RoI of an intelligent
SchahlLED Lighting project is between 12 and 36 months.
Parties have come to an agreement whereby Active Capital Company acquires a majority stake in
SchahlLED, while management further re-invests in the company. Huebner Schloesser & Cie acted as M&A
advisor to the sellers.

Strategy going forward
Over the coming years, parties expect to accelerate growth through a combination of broadening the
intelligent LED product portfolio, geographical expansion and targeted add-on acquisitions. SchahlLED is
market leader in its core DACH market and is optimally positioned to support industrial customers in
reducing their carbon footprint by providing the latest energy-efficient intelligent LED solutions. By
continuing to invest in our products and partners we aim to become the leading Pan-European turnkey
Intelligent LED service provider and become a leader in LED enabled “Industrial Internet of Things”
applications. In addition to pursuing various autonomous growth avenues there are several opportunities
for add-on acquisitions in both Germany and western Europe. Together with ACC it is our goal to bring the
benefits of our leading intelligent LED solutions to a wider European industrial client base.

Management & shareholders
Managing Directors Bernd von Doering and Erich Obermeier of SchahlLED comment: “We look forward to
partnering with Active Capital Company and together launch SchahlLED into the next growth phase.
Active Capital Company’s active involvement in its portfolio companies matches with our goal to roll-out
our strategic plan at an accelerated pace”. Mels Huige, Partner at Active Capital Company, comments: “We
are impressed with SchahlLED’s leading market position and technical expertise at the company.
SchahlLED has proven their ability to spot trends, move into new product groups and expand
geographically into new territories. We look forward to assisting the company in realizing its ambitious
goals and delivering on the growth potential of the company”.

About SchahlLED
SchahlLED is a leading turnkey service provider of Intelligent LED solutions for primarily industrial
applications. The predecessor of the company was formed in 1999, while the company was established
through a spin-off in 2006 and was acquired by management in a management buy-in in 2012. SchahlLED
is headquartered in Munich, Germany and is active throughout the DACH-region as well as in Poland. The
company is a turnkey service provider that conceptualizes and executes projects, delivering intelligent
LED lighting systems, overseeing installation and assisting in software integration and data analysis. The
company yearly serves over hundred new projects through its network of sales and service partners
located in northern Germany, central Germany, Austria, Switzerland and Poland. For further information
about SchahlLED please visit www.schahlled.de.

About Active Capital Company
Active Capital Company (“ACC”) is an independent hands-on private equity fund focused on small- and
medium sized enterprises in the Netherlands and Germany. ACC invests in companies active in the sectors
Industry, Technical Wholesale and Business Services with revenues between € 10m and € 100m. Through
a highly entrepreneurial and active approach, ACC maximizes the long-term value of its investments by
supporting management in the execution of value enhancing projects and providing access to its extensive
partner network. ACC currently invest from its third fund that has € 45m in committed capital, principally
raised from institutional investors and entrepreneurs and is in the process of raising its fourth fund. ACC
will continue to support small- and medium sized companies in realizing their full potential, both in the
Netherlands as well as Germany going forward. For further information about Active Capital Company
please visit www.activecapitalcompany.com

Categories: News

Tags:

KKR Completes Acquisition of Ramky Enviro Engineers

KKR

KKR Global Impact Makes Second Investment

MUMBAI, India–(BUSINESS WIRE)–Feb. 10, 2019– Global investment firm KKR and Ramky Enviro Engineers Limited (“REEL” or the “Company”), a leading provider of environmental services and solutions in India and overseas, today announced the completion of their previously announced transaction. Under the terms of the transaction, KKR has acquired a 60% stake in REEL for approximately US$510 million via a combination of primary and secondary investments. In addition to investing in REEL from its KKR Asian Fund III, the investment is part of KKR’s Global Impact strategy, which is focused on identifying and investing behind businesses with positive social or environmental impact that measurably contribute solutions to one or more of the United Nations Sustainable Development Goals.

This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20190210005039/en/

M. Goutham Reddy, Managing Director & CEO of REEL, said, “India is home to some of the world’s most pressing waste management needs, and REEL has an important role to play in providing critical solutions to communities across the country. KKR’s expertise in environmental issue management, extensive global and local resources, and aligned vision to enact positive change makes KKR the ideal partner to help us keep pace with the environmental challenges facing our society and provide impactful solutions. We are off to a great start with multiple strong hires added to the management team and process enhancements work to better our ESG efforts.”

Rupen Jhaveri, Managing Director at KKR, added, “Supporting promising companies that offer solutions to global challenges in areas such as the environment, health and human capital has become an increasingly important focus for KKR worldwide. REEL is exemplary in being a comprehensive environmental management company whose work supports the Swachh Bharat (Clean India) Mission to reduce pollution and improve critical sanitation infrastructure nationwide. We are confident that, with our industry experience and resources, REEL will be better positioned to achieve its social mission over the long term.”

Robert Antablin and Ken Mehlman, Co-Heads of KKR Global Impact, said, “Responsibly managing waste is a critical global challenge, particularly in one of the world’s fastest growing nations. We believe REEL will address this critical need while advancing two of the United Nations Sustainable Development Goals.”

Over the last decade, KKR has been a leader in driving and protecting value throughout the firm’s private markets portfolio through thoughtful Environmental, Social and Governance (“ESG”) management, as well as measuring and reporting on performance to the public and investors. The firm also has a history of investing in businesses that promote sustainable solutions to societal challenges. This experience of responsible investment combined with a changing landscape of global challenges led to KKR’s decision to create a dedicated Global Impact business in 2018. KKR’s Impact strategy and investment in REEL will build on this experience.

****

About Ramky Enviro Engineers

Ramky Enviro Engineers Limited (“REEL”) is a leading provider of comprehensive environmental management services. Through the provision of its technical and operational expertise, REEL offers cost-effective, custom solutions to a variety of complex environmental needs across areas including Industrial, Municipal and Medical Waste Management, Wastewater and Water Treatment, Environmental Services, Recycling and Remediation, among others. REEL today operates waste treatment facilities in more than 60 locations across India, Singapore, the Middle East, and Africa. The Company handles 3.5 million tons of municipal waste, 1 million tons of industrial waste, and caters to 20,000 healthcare establishments. Many of REEL’s facilities are ISO 9001-, ISO 14001-, ISO 17025- and OHSAS 18001-certified to ensure excellence in environmental and waste management. For more information, visit: http://ramkyenviroengineers.com.

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate and credit, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

Source: KKR

Media
KKR Asia
Anita Davis, +852 3602 7335
Anita.Davis@KKR.com
or
KKR Americas
Kristi Huller / Cara Major, +1 212-750-8300
Media@KKR.com
or
Edelman (For KKR India):
Siddharth Panicker, +91-9820-857-522
Siddharth.Panicker@Edelman.com

Categories: News

Tags:

Altamar closes latest secondary Fund on €541M

altamar-logo

The firm has announced that it has reached the final close of 541 millions of euros for its latest secondaries Fund, Altamar Global Secondaries IX FCR. The vehicle was launched in 2016 with a 500 millions of euros target, and has closed not far short of reaching its 550 millions of euros hard cap.

Categories: News

Tags:

The AFT Micromechanics Company joins the Acrotec Group

Castik Capital

Acrotec announces the entrance of AFT Micromechanics into their group.

Acrotec strengthens their diversification strategy with the addition to their group of a new company that specialise in the medical field. M Frésard, General Director of AFT Micromechanics who will remain at the head of his company, looks forward to this important move for his company. ” I am extremely happy to join the Acrotec group who will enable us to continue to advance the

Since its creation in 1997, AFT Micromechanics has specialised in the production of implants for orthopaedic and dental surgery as well as in the fields of urology, ENT and ophthalmology.

AFT benefits from extremely high-performance machining technology that guarantees impeccable quality and advantageous production costs. Since 2014, AFT has a 3D printing system for tool production and for the fast manufacturing of prototypes.

M François Billig, President of the Acrotec Group explains the logic behind this new development: “The acquisition of AFT Micromechanics is consistent with our industrial diversification plans by expanding our presence in the high precision medical field”.

 

– ENDS –

 

For further information please contact:

M.Michele Caracciolo – Tél. +41 77 410 35 60 – mcb@agencecrp.ch

About AFT Micromechanics :

Located in Fillinges, Haute Savoie (France), the company is situated along the Arve valley. Specialists for over 20 years in the machining of medical devices, they meet all the requirements of this market in order to guarantee an optimal level of quality and continual improvement, AFT Micromechnics are registered with FDA (Food and Drug Administration aux Etats-Unis). The company is certified ISO 13485/2016. www.aft-micromecanique.fr

 

About the Acrotec Group :

Acrotec is an independent group created by micromechanical professionals. Their main objective is to be the preferred subcontractor offering a wide range of precision component manufacturing processes. Their strategy is both to provide quality products « Swiss Made » to the entire watch-making industry as well as to the automotive, medical, jewellery and aeronautic industries. Acrotec distinguish themselves by their extent of know-how  provided under one roof, in their precision machining (CNC turning, multi-spindle CNC profile-turning, cam profile-turning, 3 & 5 axes milling, micro- profile-turning, transfer and machining of precious metals), by their support processes (surface treatment, gearing, assembling, heat treatment, laser decorating and engraving) and by their specific processes (UV-Liga component manufacturing, EDM, synthetic stone machining, laminating, spring shaping, design and manufacturing of machines and tooling, Silicon etching by DRIE process).  Today, the group has over 800 employees. www.acrotec.ch

 

Categories: News

Tags:

CBPE completes investment in Simbec-Orion

CBPE

CBPE Capital (“CBPE”) is pleased to announce that it has acquired Simbec-Orion Group Limited (“Simbec-Orion” or “the Company”) from the Wales Life Sciences Investment Fund LP (“WLSIF”). CBPE is investing alongside the management team led by CEO, Ronald Openshaw. The terms of the transaction have not been disclosed.

Simbec-Orion is a boutique full service clinical phase I-III contract research organisation (“CRO”) serving biotech companies and small and mid-cap pharmaceutical companies. The Company has particular specialism in the areas of oncology, rare diseases and orphan indications, respiratory conditions and translational medicine.

Simbec-Orion operates across Europe and North America and has conducted studies in more than 30 territories worldwide. It is one of the very few CROs able to offer its clients a genuine full spectrum of clinical development services including Phase I Healthy Volunteer programmes, Phase I-III patient programmes, delivering project management, clinical operations, data management, statistics, IMP management, central laboratory and pharmacovigilance services.

The investment in Simbec-Orion continues CBPE’s strong track record of investing in companies in the healthcare sector and helping to build strong, sustainable platforms for growth. The current portfolio includes Rodericks, a leading provider of NHS, private and specialist dental services; SpaMedica, which provides leading ophthalmic services; Optima Health, the largest occupational health services provider in the UK and Medica Reporting, the UK market leader in teleradiology.

CBPE’s investment in Simbec-Orion will support the continued growth of the business. CBPE will work with the management team to enhance the operations and facilities of the Company and to pursue further geographic expansion, particularly in North America and Europe.

Ronald Openshaw, Chief Executive of Simbec-Orion said:
“When Simbec-Orion was formed through the merger of Simbec Research and Orion Clinical in June 2014, it provided the base to create a growing CRO in the European mid-market. Since then, we have developed a strategy and a clearly defined and differentiated offering for our biotech and pharmaceutical clients. We are delighted to be working with CBPE to realise our ambitions for the future growth of the Company”.

Anand Jain, Partner at CBPE, said
“We have been following Simbec-Orion’s growth since the merger in 2014 and are delighted to be supporting the business through the next phase of its development. We are excited about providing Simbec-Orion with the investment and support required to further develop their services and to expand geographically both organically and through acquisitions”.

CBPE’s investment in Simbec-Orion was led by Anand Jain with support from Jolyon Latimer and Adam Richardson. Anand Jain and Adam Richardson will join the Board of Simbec-Orion.

Categories: News

Tags:

Questel acquires intellectual property services company Concur IP

ik-investment-partners

Today, Questel announces a majority investment in Concur IP, an India and US based IP services company well known for its patent drafting and standard essential patents related capabilities. This investment adds an essential piece to Questel’s existing suite of IP services. Questel can now support its clients throughout the entire IP lifecycle offering patentability search, patent drafting, translations, and international filing, as well as post grant support during licensing negotiations and litigations. Nitin Agrawal and Sachin Sinha will continue to operate as Concur IP’s Co-CEOs post this merger.

“Concur IP’s drafting service will dovetail nicely with Questel’s prior art search service,” said Charles Besson, Questel’s CEO. “Our full suite of services, including International Filing and Translation, meets a growing desire for more efficiency and clarity in connection with Intellectual Property costs, which we can now substantially guarantee to our customers”.

After noting Concur IP’s diverse experience, Nitin Agrawal, said “We believe corporate IP departments are committed to finding cost effective ways to delegate routine tasks, so they can focus their time on higher level activities. Our team of highly skilled and experienced IP professionals, having drafted more than 3,000 patent applications cumulatively, is well positioned to fulfil the demand of high quality patent applications at reasonable cost.”

Another key benefit Concur IP brings to Questel is their “Standard Essential Patent (SEP)” expertise, which is already being utilized by large telecom companies and law firms during licensing negotiations, litigations, and patent acquisitions. “Our SEP services enable companies to determine fair and reasonable licensing terms for standardized technologies. Our methodology is now well established in the market and has been adopted by the court, companies, and economists to calculate royalty rates. With Questel and their sophisticated platforms, we look forward to bringing more transparency in the process of technology standardization and the associated IP practices” said Sachin Sinha.

Questel is one of the world’s leading intellectual property management companies, delivering complete software and service solutions for each stage of the innovation lifecycle. And, for both software and services, Questel leverages a comprehensive and unique collection of intellectual property and scientific databases. With recent acquisitions of ITIP and Multiling, Questel now delivers the world’s largest and highest quality services for foreign filing of patent applications and translations. These services, when added to Questel’s e-learning and general IP consulting, make Questel the final destination to fulfill the most critical IP and Innovation needs. www.questel.com

Concur IP was formed with the specific purpose of providing high-end IP consulting services in a cost-effective manner. Concur IP’s solutions cater to various IP needs of corporates, law firms, universities, research organizations, consulting firms, and licensing support firms. Core services offerings include patent application drafting, office action responses, patent licensing & litigation support services, patent research and analytics. www.concurip.com

Categories: News

Tags: